[go: up one dir, main page]

Lane et al., 1988 - Google Patents

Anti-retroviral effects of interferon-α in AIDS-associated Kaposi's sarcoma

Lane et al., 1988

View PDF
Document ID
361748632827846536
Author
Lane H
Feinberg J
Davey V
Deyton L
Baseler M
Manischewitz J
Masur H
Kovacs J
Herpin B
Walker R
Metcalf J
Salzman N
Quinnan G
Fauci A
Publication year
Publication venue
The Lancet

External Links

Snippet

Abstract 21 patients with AIDS and Kaposi's sarcoma were enrolled in an open therapeutic trial to determine the in vivo anti-retroviral activity of recombinant interferon-α (IFN-α). 8 (38%) showed a complete or partial anti-tumour response. The mean pretreatment CD4 …
Continue reading at www.sciencedirect.com (PDF) (other versions)

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/19—Cytokines; Lymphokines; Interferons
    • A61K38/21—Interferons [IFN]
    • A61K38/212—IFN-alpha
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/19—Cytokines; Lymphokines; Interferons
    • A61K38/20—Interleukins [IL]
    • A61K38/2013—IL-2
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICRO-ORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING OR MAINTAINING MICRO-ORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2740/00—Reverse Transcribing RNA Viruses
    • C12N2740/00011—Reverse Transcribing RNA Viruses
    • C12N2740/10011—Retroviridae
    • C12N2740/16011—Human Immunodeficiency Virus, HIV
    • C12N2740/16211—Human Immunodeficiency Virus, HIV concerning HIV gagpol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A61K39/21—Retroviridae, e.g. equine infectious anemia virus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/162—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from virus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution

Similar Documents

Publication Publication Date Title
Lane et al. Anti-retroviral effects of interferon-α in AIDS-associated Kaposi's sarcoma
Molina et al. Lack of evidence for infection of or effect on growth of hematopoietic progenitor cells after in vivo or in vitro exposure to human immunodeficiency virus
Meltzer et al. Role of mononuclear phagocytes in the pathogenesis of human immunodeficiency virus infection
Novembre et al. Development of AIDS in a chimpanzee infected with human immunodeficiency virus type 1
Hoffman et al. Human T-cell leukemia virus type I infection of monocytes and microglial cells in primary human cultures.
Mackewicz et al. Effect of cytokines on HIV replication in CD4+ lymphocytes: lack of identity with the CD8+ cell antiviral factor
Kovacs et al. Combined zidovudine and interferon-α therapy in patients with Kaposi sarcoma and the acquired immunodeficiency syndrome (AIDS)
Meltzer et al. Mononuclear phagocytes as targets, tissue reservoirs, and immunoregulatory cells in human immunodeficiency virus disease
Francis et al. Induction of IFN-alpha by HIV-1 in monocyte-enriched PBMC requires gp120-CD4 interaction but not virus replication.
JPH09500362A (en) Immunity enhancement by intermittent interleukin-2 therapy
Biglino et al. Serum cytokine profiles in acute primary HIV-1 infection and in infectious mononucleosis
JOHNSON et al. Long-term observations of human immunodeficiency virus-infected chimpanzees
MORROW et al. Long-term observation of baboons, rhesus monkeys, and chimpanzees inoculated with HIV and given periodic immunosuppressive treatment
US5683701A (en) Peptide fragments of HIV
Khanna et al. Differences among HIV-1 variants in their ability to elicit secretion of TNF-α
Nakashima et al. Recombinant human interferon gamma suppresses HTLV‐III replication in vitro
Yagi et al. Human Immunodeficiency Virus Type 1 (HIV-l) Genomic Sequences and Distinct Changes in CD8+ Lymphocytes Precede Detectable Levels of HIV-l Antibodies in High-Risk Homosexuals
Kashanchi et al. Rapid and sensitive detection of cell‐associated HIV‐1 in latently infected cell lines and in patient cells using sodium‐n‐butyrate induction and RT‐PCR
Wells et al. Inhibition of human immunodeficiency virus type 1-induced cell fusion by recombinant human interferons
US5888726A (en) Pertussis toxin induced lymphocytosis
Rinaldo et al. HIV-1-specific production of IFN-gamma and modulation by recombinant IL-2 during early HIV-1 infection.
Wahl et al. Macrophage functions in HIV-1 infection
TORSETH et al. Recombinant HIV structural proteins detect specific cellular immunity in vitro in infected individuals
EP0266940B1 (en) Use of recombinant human alpha interferon for the manufacture of a medicament for the treatment of aids virus
Groopman Clinical spectrum of HTLV-III in humans